BFPT-12603

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameBFPT-12603

Drug Alias NameBFPT-2603BFPT-12603

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionImmunosuppressantsImmunoglobulin E modulators

TargetsImmunoglobulin E

Therapy Area/IndicationsRespiratory tract allergyAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBarofold

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBarofold

Active IndicationsN/A

Inactive IndicationsRespiratory tract allergyAsthma

Other Information

ATC CodeN/A